GT200500187A - Moduladores de andrògenos - Google Patents
Moduladores de andrògenosInfo
- Publication number
- GT200500187A GT200500187A GT200500187A GT200500187A GT200500187A GT 200500187 A GT200500187 A GT 200500187A GT 200500187 A GT200500187 A GT 200500187A GT 200500187 A GT200500187 A GT 200500187A GT 200500187 A GT200500187 A GT 200500187A
- Authority
- GT
- Guatemala
- Prior art keywords
- andrògen
- modulators
- compounds
- sebo
- secretion
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 2
- 230000003779 hair growth Effects 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C255/00—Carboxylic acid nitriles
- C07C255/49—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
- C07C255/54—Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/28—Antiandrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/18—Systems containing only non-condensed rings with a ring being at least seven-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/36—Systems containing two condensed rings the rings having more than two atoms in common
- C07C2602/42—Systems containing two condensed rings the rings having more than two atoms in common the bicyclo ring system containing seven carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Dermatology (AREA)
- Endocrinology (AREA)
- Physical Education & Sports Medicine (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Cosmetics (AREA)
Abstract
LA PRESENTE INVENCIÒN SE REFIERE A COMPUESTOS DE LA FÒRMULA GENERAL I EN LA QUE X1,A, SON GRUPOS FUNCIONALES DESCRITOS EN EL EXPEDIENTE. ESTOS COMPUESTOS SON MODULADORES DEL RECEPTOR DE ANDRÒGENOS POR LO QUE SON DE UTILIDAD PARA DISMINUIR LA SECRECIÒN DE SEBO Y PARA ESTIMULAR EL CRECIMIENTO CAPILAR.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US58616004P | 2004-07-08 | 2004-07-08 | |
US59803304P | 2004-08-02 | 2004-08-02 |
Publications (1)
Publication Number | Publication Date |
---|---|
GT200500187A true GT200500187A (es) | 2006-02-17 |
Family
ID=35079243
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GT200500187A GT200500187A (es) | 2004-07-08 | 2005-07-04 | Moduladores de andrògenos |
Country Status (15)
Country | Link |
---|---|
US (2) | US7670613B2 (es) |
EP (1) | EP1781598A1 (es) |
JP (1) | JP4874965B2 (es) |
AR (1) | AR049965A1 (es) |
BR (1) | BRPI0513020A (es) |
CA (1) | CA2570047C (es) |
GT (1) | GT200500187A (es) |
MX (1) | MXPA06015169A (es) |
NL (1) | NL1029457C2 (es) |
PA (1) | PA8639001A1 (es) |
PE (1) | PE20060379A1 (es) |
SV (1) | SV2006002169A (es) |
TW (1) | TW200605876A (es) |
UY (1) | UY29008A1 (es) |
WO (1) | WO2006006065A1 (es) |
Families Citing this family (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0507670A (pt) | 2004-02-13 | 2007-07-17 | Warner Lambert Co | moduladores do receptor de androgênio |
EP1737813A1 (en) | 2004-04-13 | 2007-01-03 | Warner-Lambert Company LLC | Androgen modulators |
CA2562672C (en) * | 2004-04-22 | 2009-09-29 | Warner-Lambert Company Llc | 4-cyano-phenoxy derivatives as androgen modulators |
JP4874965B2 (ja) | 2004-07-08 | 2012-02-15 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | アンドロゲン調節剤 |
BRPI0514469A (pt) * | 2004-08-18 | 2008-06-10 | Warner Lambert Co | moduladores de androgênio |
TW200724139A (en) * | 2005-05-05 | 2007-07-01 | Warner Lambert Co | Androgen modulators |
US8359450B2 (en) * | 2009-02-13 | 2013-01-22 | Opnet Technologies, Inc. | Memory utilization analysis |
RU2666530C2 (ru) | 2012-01-12 | 2018-09-11 | Йейл Юниверсити | Соединения и способы усиления деградации белков-мишеней и других полипептидов с помощью е3 убиквитин лигазы |
GB201311891D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compound |
GB201311888D0 (en) | 2013-07-03 | 2013-08-14 | Glaxosmithkline Ip Dev Ltd | Novel compounds |
US10071164B2 (en) | 2014-08-11 | 2018-09-11 | Yale University | Estrogen-related receptor alpha based protac compounds and associated methods of use |
US20170327469A1 (en) | 2015-01-20 | 2017-11-16 | Arvinas, Inc. | Compounds and methods for the targeted degradation of androgen receptor |
AU2016209349B2 (en) * | 2015-01-20 | 2020-05-07 | Arvinas, Inc. | Compounds and methods for the targeted degradation of the Androgen Receptor |
EP3370715A4 (en) | 2015-11-02 | 2019-05-15 | Yale University | CHIMERIC COMPOUNDS PROVIDED AGAINST PROTEOLYSIS AND METHOD FOR THE PRODUCTION AND USE THEREOF |
AU2017295038B2 (en) | 2016-07-15 | 2022-09-22 | Centre Hospitalier Sainte Anne Paris | 5-hydroxytryptamine 1B receptor-stimulating agent for skin and/or hair repair |
PL3660004T3 (pl) | 2016-10-11 | 2023-10-02 | Arvinas Operations, Inc. | Związki i sposoby do ukierunkowanej degradacji receptora androgenowego |
WO2021127443A1 (en) | 2019-12-19 | 2021-06-24 | Arvinas Operations, Inc. | Compounds and methods for the targeted degradation of androgen receptor |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6124343A (en) | 1919-01-27 | 2000-09-26 | Rhone-Poulenc Rorer Limited | Substituted phenyl compounds with a substituent having a thienyl ring |
US3535365A (en) | 1967-11-29 | 1970-10-20 | Merck & Co Inc | Preparation of 2,6-dichloro-4-methoxy-benzonitrile |
SU469247A3 (ru) | 1972-01-14 | 1975-04-30 | Майлз Лабораториз Инк (Фирма) | Способ получени производных хромона |
US4029493A (en) | 1973-02-23 | 1977-06-14 | Mobil Oil Corporation | Substituted phenoxybenzonitriles as herbicides |
FR2397387A1 (fr) | 1976-04-27 | 1979-02-09 | Serobiologiques Lab Sa | 4,4'-bis-formyl-polyhalo-diphenoxyalcanes, procede de preparation et application a la synthese de 4,4'-dicyano-polyhalo-diphenoxyalcanes |
US4234595A (en) | 1977-07-13 | 1980-11-18 | Mead Johnson & Company | 3-Indolyl-tertiary butylaminopropanols |
EP0002309B1 (en) | 1977-10-12 | 1982-12-01 | Imperial Chemical Industries Plc | Acylanilides, process for their manufacture and pharmaceutical and veterinary compositions containing them |
US4567201A (en) | 1981-11-25 | 1986-01-28 | Takeda Chemical Industries, Ltd. | Diphenoxypropane derivatives and compositions of antiasthmatic and antiinflammatory agents thereof |
GB8504093D0 (en) | 1985-02-18 | 1985-03-20 | Ici Plc | Alkene alkyne/cycloalkylene derivatives |
ATE28864T1 (de) | 1982-07-23 | 1987-08-15 | Ici Plc | Amide-derivate. |
EP0107759B1 (de) | 1982-08-26 | 1992-12-16 | MERCK PATENT GmbH | Cyclohexanderivate und ihre Verwendung als Komponenten Flüssigkristalliner-Dielektrika |
JPS59144747A (ja) | 1983-02-04 | 1984-08-18 | Chisso Corp | 2−クロロ−4−アルキルオキシベンゾニトリル化合物 |
US4536321A (en) | 1983-02-18 | 1985-08-20 | Chisso Corporation | Fluorobenzene derivatives and liquid crystal compositions containing the same |
JPS63227502A (ja) | 1987-03-17 | 1988-09-21 | Sds Biotech Kk | 防菌防カビ剤 |
US4992433A (en) | 1987-11-23 | 1991-02-12 | Janssen Pharmaceutica N.V. | Novel pyridazinamine derivatives |
US4925590A (en) | 1988-03-10 | 1990-05-15 | Merck Patent Gesellschaft Mit Beschrankter Haftung | Derivatives of 4-cyano-2,3-difluorophenol |
DE3825170A1 (de) | 1988-07-23 | 1990-01-25 | Hoechst Ag | Substituierte 5-(4-(4,5-dihydro-2-oxazolyl)-phenoxyalkylenoxyalkyl)-isoxazole, verfahren sowie 5-(phenoxyalkylenoxyalkyl)-isoxazole als zwischenprodukte zu ihrer herstellung und ihre verwendung zur bekaempfung von krankheiten, die durch infektion mit viren hervorgerufen wurden |
DE4017019A1 (de) | 1990-05-26 | 1991-11-28 | Hoechst Ag | Verwendung von substituierten ss-hydroxyethylaminen als potente hemmstoffe der exoenzyme von pilzen |
JPH04124183A (ja) | 1990-09-14 | 1992-04-24 | Mitsubishi Rayon Co Ltd | 光学活性パントラクトン誘導体 |
JP3088777B2 (ja) | 1991-03-27 | 2000-09-18 | 富士薬品工業株式会社 | 新規光学分割剤及びそれを用いる光学活性アミンの製造方法 |
JP3151929B2 (ja) | 1992-05-15 | 2001-04-03 | 大日本インキ化学工業株式会社 | フルオロシクロヘキセン誘導体 |
DE4217928A1 (de) | 1992-05-30 | 1993-12-02 | Hoechst Ag | Neue Mischungen aus Herbiziden und Antidots, neue (Hetero-)Aryloxy-Verbindungen, Verfahren zu deren Herstellung, diese enthaltenden Mittel und deren Verwendung |
JPH0641038A (ja) | 1992-07-17 | 1994-02-15 | Mitsubishi Kasei Corp | カルボン酸誘導体 |
US5455274A (en) | 1992-12-09 | 1995-10-03 | Ciba-Geigy Corporation | Hydroxyamidine derivatives |
US5316755A (en) | 1993-02-02 | 1994-05-31 | Sterling Winthrop Inc. | Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract |
GB2278054A (en) | 1993-05-18 | 1994-11-23 | Zeneca Ltd | Compounds for the treatment of urinary incontinence |
TW262553B (es) | 1994-03-17 | 1995-11-11 | Hitachi Seisakusyo Kk | |
AU1897795A (en) | 1994-04-21 | 1995-11-16 | Nycomed Imaging As | X-ray contrast compositions containing pharmaceutically acceptable clays |
JPH07309850A (ja) | 1994-05-16 | 1995-11-28 | Canon Inc | 光学活性化合物、それを含有する液晶組成物、それを有する液晶素子及びそれらを用いた表示方法、表示装置 |
EP0684235A1 (en) | 1994-05-27 | 1995-11-29 | Mochida Pharmaceutical Co., Ltd. | Novel azolyl methyl phenyl derivatives having aromatase inhibitory activity |
ES2169102T3 (es) | 1994-10-14 | 2002-07-01 | Merck Patent Gmbh | (r)-(-)-2-(5-(4-fluorfenil)-3-piridilmetilaminometil)-cromano como agente activo sobre el sistema nervioso central. |
JP3802581B2 (ja) * | 1995-03-01 | 2006-07-26 | 富山化学工業株式会社 | 新規なビフェニル誘導体またはその塩およびそれらを含有する抗炎症剤 |
JPH0953018A (ja) * | 1995-06-09 | 1997-02-25 | Mitsubishi Chem Corp | フタロシアニン誘導体及び該誘導体を使用した光学記録媒体 |
US5656651A (en) * | 1995-06-16 | 1997-08-12 | Biophysica Inc. | Androgenic directed compositions |
DE19534209A1 (de) | 1995-09-15 | 1997-03-20 | Jenapharm Gmbh | Hormonales Mittel zur Behandlung der Haut |
ES2127106B1 (es) | 1996-03-21 | 1999-11-16 | Menarini Lab | Derivados benzopiranicos con accion antagonista de los leucotrienos, procedimiento para su preparacion y utilizacion de los mismos. |
US5847166A (en) * | 1996-10-10 | 1998-12-08 | Massachusetts Institute Of Technology | Synthesis of aryl ethers |
US6071957A (en) * | 1996-11-27 | 2000-06-06 | The University Of Tennessee Research Corporation | Irreversible non-steroidal antagonist compound and its use in the treatment of prostate cancer |
EP1019384A1 (en) | 1997-02-04 | 2000-07-19 | Dong Wha Pharmaceutical Industrial Co. Ltd. | 3-amino-1,2-benzoisoxazole derivatives, process for preparation, and use thereof |
US6013668A (en) | 1997-08-13 | 2000-01-11 | Bristol-Myers Squibb Company | Enantiomers of 4-[[(cyanoimino) [(1,2,2-trimethylpropyl) amino]methyl]amino]benzonitrile |
US6297239B1 (en) | 1997-10-08 | 2001-10-02 | Merck & Co., Inc. | Inhibitors of prenyl-protein transferase |
US6184249B1 (en) | 1998-12-18 | 2001-02-06 | Biophysica, Inc. | Androgen receptor suppressors in the therapy and diagnosis of prostate cancer, alopecia and other hyper-androgenic syndromes |
JP2003508402A (ja) * | 1999-08-27 | 2003-03-04 | リガンド・ファーマシューティカルズ・インコーポレイテッド | アンドロゲン受容体モジュレーター化合物および方法 |
WO2001056989A2 (en) | 2000-02-01 | 2001-08-09 | Cor Therapeutics, Inc. | Inhibitors of factor xa |
ATE384036T1 (de) | 2000-07-13 | 2008-02-15 | Merck Patent Gmbh | Chirale verbindungen i |
SI1401801T1 (sl) * | 2000-08-24 | 2007-04-30 | Univ Tennessee Res Foundation | Selektivni modulatorji androgenskega receptorja in postopki za njihovo uporabo |
WO2002018333A1 (en) | 2000-08-31 | 2002-03-07 | Pfizer Limited | Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors |
AU2002211805A1 (en) | 2000-09-06 | 2002-03-22 | Emisphere Technologies, Inc. | Cyanophenoxy carboxylic acid compounds and compositions for delivering active agents |
AU9419701A (en) * | 2000-10-06 | 2002-04-22 | Tanabe Seiyaku Co | Aliphatic nitrogenous five-membered ring compounds |
US6646012B2 (en) | 2001-01-16 | 2003-11-11 | Theravance, Inc. | Sodium channel modulators |
PL364910A1 (en) | 2001-01-31 | 2004-12-27 | Pfizer Products Inc. | Ether derivatives useful as inhibitors of pde4 isozymes |
WO2002085860A1 (en) | 2001-04-10 | 2002-10-31 | Pfizer Limited | Pyrazole derivatives for treating hiv |
AR035700A1 (es) | 2001-05-08 | 2004-06-23 | Astrazeneca Ab | Derivados de arilheteroalquilamina, composicion farmaceutica, usos de estos derivados para la fabricacion de medicamentos, metodos de tratamiento, y proceso para la preparacion de estos derivados |
EA200901492A1 (ru) | 2002-02-07 | 2010-08-30 | Юниверсити Оф Теннесси Рисерч Фаундейшн | Лечение доброкачественной гиперплазии простаты селективным модулятором рецептора андрогенов (sarm) |
TW200302722A (en) | 2002-02-13 | 2003-08-16 | Astrazeneca Ab | Therapeutic agents |
MXPA04007870A (es) | 2002-02-15 | 2005-06-20 | Endorech Inc | Derivados de bifenilo y su uso como agentes antiandrogenicos. |
AU2003214971A1 (en) | 2002-02-28 | 2003-09-16 | University Of Tennessee Research Foundation | Irreversible selective androgen receptor modulators and methods of use thereof |
AU2003230700A1 (en) | 2002-03-26 | 2003-10-13 | Boehringer Ingelheim Pharmaceuticals, Inc. | Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
US6875438B2 (en) | 2002-04-27 | 2005-04-05 | Aventis Pharma Deutschland Gmbh | Preparations for topical administration of substances having antiandrogenic activity |
DE10218963A1 (de) * | 2002-04-27 | 2003-11-20 | Aventis Pharma Gmbh | Zubereitungen zur topischen Applikation von antiandrogen wirksamen Substanzen |
US6951884B2 (en) | 2002-06-12 | 2005-10-04 | Hoffmann-La Roche Inc. | Fluorobenzamides and uses thereof |
US7582230B2 (en) | 2002-08-14 | 2009-09-01 | Ciba Specialty Chemicals Corporation | Liquid crystal display and colour filter with improved transparency for green light |
WO2004018386A2 (en) | 2002-08-26 | 2004-03-04 | Merck & Co., Inc. | Acetophenone potentiators of metabotropic glutamate receptors |
KR101072236B1 (ko) * | 2002-09-19 | 2011-10-12 | 아보트 러보러터리즈 | 디펩티딜 펩티다제-iv(dpp-iv)의 억제제로서의약제학적 조성물 |
MXPA05013756A (es) | 2003-06-18 | 2006-03-08 | Pfizer Prod Inc | Piperazinil-ariloxi y piperazinil-heteroariloxi-n-aril-lactamas novedosas. |
FI20030958A0 (fi) | 2003-06-27 | 2003-06-27 | Orion Corp | Uusia yhdisteitä |
TW200524888A (en) | 2003-08-08 | 2005-08-01 | Vertex Pharma | Compositions useful as inhibitors of voltage-gated ion channels |
GB0324551D0 (en) | 2003-10-21 | 2003-11-26 | Karobio Ab | Novel compounds |
JP2007521328A (ja) | 2003-11-20 | 2007-08-02 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | アンドロゲン受容体モジュレーター |
BRPI0507670A (pt) | 2004-02-13 | 2007-07-17 | Warner Lambert Co | moduladores do receptor de androgênio |
EP1737813A1 (en) | 2004-04-13 | 2007-01-03 | Warner-Lambert Company LLC | Androgen modulators |
CA2562672C (en) | 2004-04-22 | 2009-09-29 | Warner-Lambert Company Llc | 4-cyano-phenoxy derivatives as androgen modulators |
WO2005108361A1 (en) | 2004-05-07 | 2005-11-17 | Janssen Pharmaceutica N.V. | Adamantyl pyrrolidin-2-one derivatives as 11-beta hydroxysteroid dehydrogenase inhibitors |
JP4874965B2 (ja) | 2004-07-08 | 2012-02-15 | ワーナー−ランバート カンパニー リミテッド ライアビリティー カンパニー | アンドロゲン調節剤 |
BRPI0514469A (pt) | 2004-08-18 | 2008-06-10 | Warner Lambert Co | moduladores de androgênio |
KR20070049238A (ko) | 2004-08-31 | 2007-05-10 | 워너-램버트 캄파니 엘엘씨 | 안드로겐 조절제 |
PL1807072T3 (pl) | 2004-10-29 | 2009-06-30 | Lilly Co Eli | Cykloalkilowe pochodne laktamów jako inhibitory 11-ß-HSD1 |
TW200724139A (en) | 2005-05-05 | 2007-07-01 | Warner Lambert Co | Androgen modulators |
-
2005
- 2005-06-27 JP JP2007519910A patent/JP4874965B2/ja not_active Expired - Fee Related
- 2005-06-27 MX MXPA06015169A patent/MXPA06015169A/es active IP Right Grant
- 2005-06-27 WO PCT/IB2005/001999 patent/WO2006006065A1/en active Application Filing
- 2005-06-27 CA CA2570047A patent/CA2570047C/en not_active Expired - Fee Related
- 2005-06-27 BR BRPI0513020-4A patent/BRPI0513020A/pt not_active IP Right Cessation
- 2005-06-27 EP EP05757544A patent/EP1781598A1/en not_active Withdrawn
- 2005-07-04 GT GT200500187A patent/GT200500187A/es unknown
- 2005-07-05 US US11/175,097 patent/US7670613B2/en not_active Expired - Fee Related
- 2005-07-06 PE PE2005000789A patent/PE20060379A1/es not_active Application Discontinuation
- 2005-07-06 AR ARP050102808A patent/AR049965A1/es unknown
- 2005-07-07 UY UY29008A patent/UY29008A1/es not_active Application Discontinuation
- 2005-07-07 TW TW094123000A patent/TW200605876A/zh unknown
- 2005-07-07 NL NL1029457A patent/NL1029457C2/nl not_active IP Right Cessation
- 2005-07-08 SV SV2005002169A patent/SV2006002169A/es not_active Application Discontinuation
- 2005-07-08 PA PA20058639001A patent/PA8639001A1/es unknown
-
2009
- 2009-11-05 US US12/546,103 patent/US20100048517A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
SV2006002169A (es) | 2006-02-15 |
JP2008505880A (ja) | 2008-02-28 |
NL1029457A1 (nl) | 2006-01-10 |
PE20060379A1 (es) | 2006-05-27 |
NL1029457C2 (nl) | 2006-08-02 |
TW200605876A (en) | 2006-02-16 |
US20060009427A1 (en) | 2006-01-12 |
WO2006006065A1 (en) | 2006-01-19 |
CA2570047A1 (en) | 2006-01-19 |
AR049965A1 (es) | 2006-09-20 |
PA8639001A1 (es) | 2006-06-02 |
UY29008A1 (es) | 2006-03-31 |
US20100048517A1 (en) | 2010-02-25 |
JP4874965B2 (ja) | 2012-02-15 |
CA2570047C (en) | 2010-09-28 |
US7670613B2 (en) | 2010-03-02 |
EP1781598A1 (en) | 2007-05-09 |
MXPA06015169A (es) | 2007-08-21 |
BRPI0513020A (pt) | 2008-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GT200500187A (es) | Moduladores de andrògenos | |
CY1123338T1 (el) | Νεοι ρυθμιστες υποδοχεων φωσφορικης σφιγγοσινης | |
GT200500185A (es) | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
GT200500183A (es) | Moduladores del receptor de progesterona que comprenden derivados de pirrol-oxindol y sus usos | |
ECSP088210A (es) | Bencimidazoles sustituidos y métodos de preparación | |
GT200500226A (es) | Compuestos de aminoheteroarilo sustituidos con pirazol como inhibidores de proteina quinasa | |
ECSP067121A (es) | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas | |
GT200600197A (es) | Compuestos y composiciones como inhibidores de proteina quinasa | |
GT201200189A (es) | Antagonistas de pcsk9 | |
ECSP067120A (es) | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas | |
ECSP11011019A (es) | Antagonistas del receptor de orexina de isonicotinamida | |
CR10433A (es) | Compuestos organicos y sus usos | |
GT200600430A (es) | Compuestos de carboxiamina y metodos de uso de los mismos | |
SV2010003662A (es) | Derivados de azetidina y ciclobutano como inhibidores de jak ref. x-19081 | |
CR20110206A (es) | Método de uso de una sepa de bacillus subtilis para mejorar la salud de animales | |
CO6300954A2 (es) | Derivados de tienopiridinonas como activadores de proteina quinasa activados por ampk | |
GT200500101A (es) | Compuestos de metil-aril o heteroaril-amida sustituida | |
BRPI0813966A8 (pt) | Usos de mdl-1 | |
DE602007012072D1 (de) | Orantagonisten | |
PA8662501A1 (es) | Compuestos de bis arilo y heteroarilo sustituidos como agentes selectivos de 5ht2a | |
SV2009003349A (es) | Compuestos triciclicos, composiciones y procedimientos | |
GT200600174A (es) | Pirrolopiridinas sustituidas, composiciones que las contienen, proceso de fabricacion y utilizacion | |
CL2009000990A1 (es) | Uso de epotilona d para el tratamiento de enfermedades asociadas a tau, tal como enfermedad alzheimer, parkinson, entre otras. | |
CR10060A (es) | 3-aminociclopentanocarboxamidas como moduladores de receptores de quimioquinas | |
GT200600030A (es) | 2-fenil-indoles como antagonistas del receptor de la prostaglandina d2 |